Healthcare Industry Joins Forces to Create New Digital Services

Twenty-one leading healthcare organisations have joined a formal partnership to tackle the nation’s healthcare challenges by accelerating growth in the digital healthcare market. Founded and led by D Health, the partnership known as ‘the Catalyst’ involves major brands Celisio (owners of Lloyds Pharmacy) and Johnson and Johnson's LifeScan. Other founding members include SMEs such as Isansys, Grey Matters and Cardio QT and healthcare providers Red House Practice Group, Just Checking and Physiomedics. Amongst others, third sector representatives Highland Hospice and Albyn Housing Society have also signed up alongside supporting organisations corporate financiers Opus, sales business Trocar and a leading consumer psychologist.

Advanced talks with potential members from other UK organisations are currently underway, whilst plans to expand the group into Europe during 2014 have progressed with the addition of Spanish cooperative, TIC Biomed to the group.

The Catalyst is set to meet for the first time in London on 5 February 2014 to discuss how it can provide new, low cost products and services for both consumer and provider markets. These could include innovations such as fitness boosting smart phone apps, blood monitoring devices, TV and phone based services for the elderly and self-management software for diabetics.

Market projections for digital healthcare vary widely, but all point to rapid growth over coming years as demand for services increases. According to a recent report conducted by Frost and Sullivan, the worldwide market for healthcare devices will garner over $509.25 billion in the next 10 years, up 87.5 per cent from $271.55 billion in the current decade.

CEO Dr Steven Dodsworth, formerly a scientist with the UK arm of the Human Genome project, leads D Health. He said: "Everyone in the healthcare industry knows what challenges lie ahead - an ageing population, more lifestyle-related ill health and growing constraints on budgets. In a nutshell, there is an increasing demand for services but fewer resources to deliver them.

"Digital healthcare has the potential to deliver popular, personalised, efficient and affordable patient services, and yet, the market isn’t growing fast enough to alleviate pressure on the NHS and local authorities.

"By creating a partnership that embodies all sections of the healthcare industry we aim to create not only new products and services but a new market dynamic based on collaboration. That way the industry can develop urgently required services that support and supplement sustainable health and care services for the future."

Ken Spooner from the Red House Group of Surgeries added: "The Catalyst offers the opportunity for developers of digital healthcare products to work with those who understand patients' needs, helping them to come up with solutions that can deliver and be part of the NHS healthcare offering in the future."

For further information, please visit:
http://www.dhcl.org

Digital healthcare is a holistic term incorporating telemedicine, telehealth, telecare, E-Health, M-Health, Health IT and Assisted Living. As aging populations, lifestyle related diseases and other social and economic drivers continue to dominate global healthcare systems, digital healthcare is rapidly emerging as a key solution for delivering sustainable health and care for the future.

D Health is a specialist consultancy which provides support services to the global digital healthcare community. Combined, D Health’s core team has over 70 years of experience in healthcare as academics, public servants, industry professionals and business leaders. Calling on its industry experience and networks, D Health’s expertise lies in its ability to identify funding, provide market intelligence, scope opportunities, design business/service models and broker partnerships.

The D Health Catalyst is a market accelerator programme that aims to work with leading organisation from the UK and Europe to drive rapid development of the digital healthcare market. D Health aims to stimulate interaction and development by ensuring the Catalyst represents a full cross-section of the market, from SMEs and blue chip companies to state providers and investors. By achieving this, Catalyst members can work in true collaboration, giving them new insight whilst reducing risk, thereby providing a competitive edge.

Most Popular Now

European Artificial Intelligence Act Com…

The European Artificial Intelligence Act (AI Act), the world's first comprehensive regulation on artificial intelligence, enters into force. The AI Act is designed to ensure that AI developed and used...

Patient Safety must be Central to the De…

An EPR system brings together different patient information in one place, making it easier to access for healthcare professionals. This information can include patients' own notes, test results, observations by...

ChatGPT Shows Promise in Answering Patie…

The groundbreaking ChatGPT chatbot shows potential as a time-saving tool for responding to patient questions sent to the urologist's office, suggests a study in the September issue of Urology Practice®...

Survey: Most Americans Comfortable with …

Artificial intelligence (AI) is all around us - from smart home devices to entertainment and social media algorithms. But is AI okay in healthcare? A new national survey commissioned by...

AI Spots Cancer and Viral Infections at …

Researchers at the Centre for Genomic Regulation (CRG), the University of the Basque Country (UPV/EHU), Donostia International Physics Center (DIPC) and the Fundación Biofisica Bizkaia (FBB, located in Biofisika Institute)...

Video Gaming Improves Mental Well-Being

A pioneering study titled "Causal effect of video gaming on mental well-being in Japan 2020-2022," published in Nature Human Behaviour, has conducted the most comprehensive investigation to date on the...

New Diabetes Research Links Blood Glucos…

As part of its ongoing exploration of vocal biomarkers and the role they can play in enhancing health outcomes, Klick Labs published a new study in Scientific Reports - confirming...

Machine learning helps identify rheumato…

A machine-learning tool created by Weill Cornell Medicine and Hospital for Special Surgery (HSS) investigators can help distinguish subtypes of rheumatoid arthritis (RA), which may help scientists find ways to...

New AI Software could Make Diagnosing De…

Although Alzheimer's is the most common cause of dementia - a catchall term for cognitive deficits that impact daily living, like the loss of memory or language - it's not...

A New AI Tool for Cancer

Scientists at Harvard Medical School have designed a versatile, ChatGPT-like AI model capable of performing an array of diagnostic tasks across multiple forms of cancers. The new AI system, described Sept...

Vision-Based ChatGPT Shows Deficits Inte…

Researchers evaluating the performance of ChatGPT-4 Vision found that the model performed well on text-based radiology exam questions but struggled to answer image-related questions accurately. The study's results were published...

Bayer Launches New Healthy-Aging Ecosyst…

Combining a scientifically formulated dietary supplement, a leading-edge wellness companion app, and a saliva-based a biological age test by Chronomics, Bayer is taking a big step in the emerging healthy-aging...